IntroDuctIon
Alzheimer's disease (AD), the most common cause of senile dementia 1 , is characterized pathologically by the formation of amyloid plaques and neurofibrillary tangles in the brain 2 . The principal components of amyloid plaques are the fibrillar aggregates of amyloid-β (Aβ) peptides 3 (39-43 amino acids), which are produced as a result of enzymatic proteolysis of amyloid precursor protein (APP) in neurons and other cells throughout life [4] [5] [6] . Strong circumstantial evidence from genetics, pathology, biochemical studies and animal models led to the emergence of the Aβ amyloid cascade hypothesis of AD 7, 8 . This hypothesis stipulates a central role of Aβ production, oligomerization and/or fibrillogenesis ( Fig. 1) in triggering a cascade of cellular and molecular events, which lead to the development of synaptic failure, synapse loss, neuronal loss and eventually dementia. Missing links between this cascade and AD pathogenesis include the identification of the mechanisms by which the process of Aβ aggregation contributes to neurodegeneration and to the identity of the toxic Aβ species. This knowledge is crucial for developing effective strategies to prevent and/or treat AD. Furthermore, the identification of specific aggregation states, which correlate with neurodegeneration in AD, could lead to the development of diagnostic tools to detect and monitor disease progression. Such tools are crucial for evaluating the efficacy of therapies at different stages of AD pathogenesis.
In solution, Aβ is unstructured, but acquires a β-sheet structure on aggregation and amyloid formation. Amyloid formation by Aβ follows a nucleation polymerization pathway that is characterized by an initial lag phase dominated by monomeric (M) species, followed by formation of low-molecularweight (LMW) oligomers (dimer, trimers and < 8-mers) 9, 10 .
A β-sheet-rich oligomeric 'nucleus' subsequently forms from these aggregates, which undergoes further growth to form higherorder aggregates of heterogeneous size and morphology distribution ( Table 1) . These β-sheet-rich oligomeric intermediates are collectively referred to as prefibrillar aggregates and disappear on fibril formation [11] [12] [13] . Some of the well-documented prefibrillar morphologies include protofibrils (curvilinear structures less than 200 nm in length and 4-6 nm in diameter) [12] [13] [14] , Aβ-derived diffusible ligands (ADDLs; spherical aggregates 3-5 nm in diameter) 15 , Aβ-annular assemblies (doughnut-like structures; outer diameter 8-12 nm and inner diameter 2-2.5 nm) [16] [17] [18] and LMW oligomers 17, 19 ( Table 1) . Whether some of these species represent off-or on-pathway intermediates to amyloid fibril formation remains unknown. Some of the key distinguishing features of protofibrillar aggregates are that they (i) contain a mixture of different secondary structure elements with a predominance of β-sheet 20 ; (ii) bind amyloid-specific dyes, such as Congo red and Thioflavin-T (ThT), although less strongly than mature fibrils [20] [21] [22] ; and (iii) are less stable than mature amyloid fibrils and exist in equilibrium with monomeric Aβ 20, 21, 23 . In the presence of monomeric Aβ, all these species convert to mature amyloid fibrils by monomer addition. Mature amyloid fibrils have been described as insoluble, β-sheet-rich structures that are more than 1 µm long, 8-12 nm in diameter and composed of 2-6 protofilament subunits 24, 25 . In vitro, synthetic and recombinant forms of Aβ peptides have been shown to form aggregates and amyloid fibrils that are indistinguishable from the ones isolated from AD brain [26] [27] [28] . This suggests that the physiological process of amyloid formation can be recapitulated in vitro and highlights Several studies using familial AD (fAD) mutations in animal models and cell culture experiments strongly support the notion that early intermediates in the fibrillization process (i.e., oligomers, including protofibrils) are the primary toxic Aβ species and have a central role in AD pathogenesis. This hypothesis is supported by (i) the lack of a clear correlation between fibrillar amyloid burden in AD patients and cognitive impairment 29, 30 , whereas such a correlation has been reported for the soluble pool of Aβ (monomers and oligomers including protofibrils) and AD severity 31, 32 ; (ii) the fact that autosomal dominant mutations in APP or its cleaving enzymes (presenilins), which favor increased production of Aβ42 and/or accumulation of protofibrils, are associated with the development of fAD [33] [34] [35] [36] ; (iii) the indication that transgenic animals overexpressing fAD mutations in APP exhibit learning deficits and lower performance in memory tasks, compared with control animals, long before the appearance of amyloid plaques 37, 38 ; (iv) the fact that intracerebral administration of soluble Aβ oligomers in live animals impairs cognitive performance and inhibits long-term potentiation (LTP), a cellular model of memory formation 19 , and induces widespread plaque pathology 39 ; and (v) the observation that treating cultured neurons with Aβ protofibrils results in impairment of ion channelss 40, 41 , inhibition of LTP 42 , loss of synapses and cell death 14 . Finally, anti-Aβ antibodies specifically targeting oligomers, including protofibrils, block neurotoxicity in cultured neurons 43 and reverse behavioral deficits in mice 44 . Therefore, there is a vast academic, medical and commercial interest in identifying therapeutic agents that target specifically soluble Aβ (monomers and oligomers, including protofibrils) and their impact on AD pathogenesis.
Studies using animal models of AD or using cultured neurons suggest that prefibrillar Aβ aggregates, including LMW oligomers and protofibrils, exert their toxic effects by several potentially interrelated mechanisms, including pore formation 45 , channel-like activity 46 , permeabilization of lipid bilayers 47 , inhibition of K + currents in cortical cultures 40 , disruption of neuronal glutamate uptake 48 , activation of apoptosis 49 , oxidative damage 50 and degradation of postsynaptic density marker PSD- 95 (ref. 51) . A definitive correlation of any of these biological effects with the development and progression of AD is not straightforward and remains difficult to establish. A detailed molecular understanding of the process of amyloid formation, as well as the structural properties and dynamics of the various prefibrillar intermediates, is crucial for understanding the role of amyloid formation in AD pathogenesis. This requires access to experimental protocols that allow the preparation of sufficient quantities of well-characterized Aβ aggregate states for structural and functional studies.
Various methods have been used to prepare different oligomeric and protofibrillar Aβ species from synthetic Aβ (sAβ) peptides, and each method has its own advantages and disadvantages. Treatment of lyophilized Aβ with strong acids and bases to disrupt preformed aggregates and enhance solubility 52 , filtration through LMW cutoff filters 53 , photo-induced crosslinking of unmodified proteins 17 , density gradient centrifugation 54 and size exclusion chromatography (SEC) 13, 14, 17 have all been used to prepare soluble aggregates of Aβ and yield preparations that vary in size and morphology distribution. SEC, in particular, offers several advantages: (i) a variety of column matrices with different separation capacities are readily available and can be used in isolation or in combination with other columns to obtain high-resolution separation and fractions containing Aβ aggregates of defined size distribution; (ii) generally, the columns are equipped with filters at the top that allow for the removal of fibrillar (or insoluble) material from the injected sample, thus ensuring that the Aβ fractions are free of fibrillar seeds; (iii) if SEC is coupled to a light-scattering detector, accurate determination of Aβ aggregates' size distribution becomes possible 20 ; (iv) in analytical mode, SEC is a valuable tool to monitor early events in amyloid formation and quantification of monomer and/or protofibril loss during the time course of fibril formation 21 ; and (v) by choosing proper running conditions (i.e., buffer pH and contents), fractions are obtained in solution conditions suitable for biological systems, free of harmful or undesired substances (e.g., organic solvents and so on). SEC has also been successfully used to isolate Aβ oligomers (such as dimers and trimers) and high-molecular-weight aggregates (including protofibrils and amorphous aggregates) from complex cell culture media 55 or from postmortem AD brain extracts 56 . Although it is one of the most commonly used methods for isolating and purifying Aβ oligomers 13, 21, 23 , SEC suffers from certain drawbacks that should be taken into consideration when using this technique: (i) some aggregates, because of their variable stability, may dissociate on interacting with column matrix and elute as LMW species 21 ; (ii) there may be a low resolution of separation if the sample is composed of a continuum of interconverting aggregates of related sizes; (iii) the samples are diluted in concentration after SEC fractionation and may not be suitable for use in certain experiments requiring high Aβ concentration; (iv) long duration of separation may allow interconversion and mask changes taking place within the time scale of minutes or less; (v) interactions with column matrices and separation may also be affected by factors other than size, such as aggregate conformation and tertiary structure; and (vi) nonspecific adsorption of hydrophobic peptides (such as Aβ) to the column matrix might result in a low yield of purified material.
Previous results obtained using this protocol
The early reports showing the appearance of protofibrils during the course of amyloid fibril formation in vitro 12 heightened the interest in obtaining these structures in purified form 13 . Using SEC, several groups showed that they can isolate protofibrillar aggregates, thus making it possible to elucidate their structural features and compare their toxicity with purified monomers or fibrils 14, 20 . These studies have contributed significantly to (i) our current understanding of the mechanism of amyloid formation and its potential role in the pathogenesis of AD; (ii) our knowledge of the physical and structural properties of different oligomeric and protofibrillar Aβ species; and (iii) the development of important research tools 
Oligomers
The term 'oligomers' encompasses a wide range of species, ranging from low-molecular-weight (LMW) species (including dimers, trimers and tetramers) to high-molecular-weight (HMW) oligomeric species (such as spherical, chain-like and annular structures or longer structures ( Fig. 4e-g) ). Fibrils are, by definition, protein oligomers. Different types of oligomeric species have been described and are typically distinguished by their composition, stability and molecular weight 13, 15, [17] [18] [19] LMW oligomers Generally, LMW oligomer preparations contain a mixture of species that are less than 8-mers and are in equilibrium with monomeric Aβ, as determined by denaturing SDS-PAGE gels or cross-linking studies. These species are generally not detectable by standard TEM techniques. The smallest Aβ oligomer species that could be visualized and its size determined by STEM was of 42-80 kDa. Evidence for the LMW oligomers has been primarily derived from denaturing SDS-PAGE electrophoresis experiments and crosslinking studies. There is no evidence that these species accumulate in a stable form. Furthermore, the possibility that these oligomers could be derived from HMW oligomers has not been ruled out
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SDS-stable LMW oligomers
SDS-resistant LMW oligomers ( < 8-mers) have been prepared in vitro or isolated from natural sources (cell cultures or brain tissues). LMW oligomers that are secreted from CHO cells overexpressing wild-type APP, or APP bearing fAD mutations, exhibit strong stability to SDS and chemical-induced dissociations, whereas the majority of LMW oligomers generated in vitro by separation through a SEC column are SDS sensitive, unless stabilized by chemical cross-linking. Naturally secreted LMW oligomers were shown to inhibit LTP and impair cognitive performance when injected into rat brains at much lower concentration than that used to observe toxicity with synthetic Aβ. However, despite extensive efforts by different laboratories to establish the chemical identity and true stoichiometry of naturally formed SDS-stable oligomers/aggregates by mass spectrometry, such data remain lacking and current size estimates are solely based on their mobility in denaturing gels
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High molecular weight
Metastable Aβ heterogeneous oligomers that can be visualized by TEM and AFM and range in size from ~42 kDa to > 1 mDa 12, 13, 15, 16, 18, 20, 21, 93 • Protofibrils Metastable, heterogeneous, -sheet rich prefibrillar structures that have been observed by AFM and TEM during amyloid fibril formation. Different protofibril preparations of Aβ reveal heterogeneous mixtures of discrete β-sheet aggregates of different sizes (50-1,500 kDa) and morphologies (spherical (5-20 nm), annular structures and smooth, curvilinear structures (5 nm in diameter and < 200 nm in length)). TEM and AFM studies support a structural link between some of these different aggregates, but the mechanisms by which they form, the dynamics of their interconversion and their relationship with the amyloid fibrils remain poorly understood. Although protofibrils were initially thought to be on the linear pathway to fibrils, in its current usage, this term embraces all prefibrillar aggregates (≥4 nm) that can be detected by EM and AFM. Protofibrils bind to Congo red and Thioflavin, although to a lesser extent than mature fibrils. Therefore, protofibrils here are kinetic intermediates, whereas protofilaments (see definition given above) represent the substructure of the amyloid fibril 12,20,21
•ADDLs Globular structures of 3-5 nm in diameter. Also referred to as globulomers. Initial reports, using mainly AFM and denaturing SDS-PAGE electrophoresis, suggested that these preparations contain primarily small oligomers ~10-12-mers. However, subsequent solution characterization of the ADDL preparations showed that they consist of a heterogeneous population of A species, encompassing molecular sizes ranging from monomers to aggregates larger than 1 mDa, resembling the distribution observed for protofibrils (such as conformational antibodies) and of novel amyloid-based diagnostic tools and therapeutic strategies.
Structural and mechanistic studies. The ability to purify protofibrils in sufficient quantities has facilitated biophysical and structural studies aimed at characterizing their structure and toxic properties. Biophysical studies, using multiple techniques, on SEC-purified Aβ protofibrils revealed many important structural and physical features that distinguish these species from monomeric and fibrillar forms of Aβ. Aβ protofibrils were shown to (i) bind amyloid-specific dyes such as Congo red and ThT 18, 20, 21 ; (ii) be enriched with a β-sheet structure 20 ; (iii) possess a core structure protected from solvent 20, 21, 23 ; and (iv) exist in equilibrium with monomeric Aβ 20, 21, 23 . Quasielastic light-scattering measurements revealed that SEC-purified Aβ protofibrils contained aggregates with hydrodynamic radii (R H ) of 10-50 nm, which correspond to lengths of ~30-500 nm for noninteracting rods 13 . The heterogeneity of protofibrils was further elucidated by scanning transmission electron microscopy (TEM) 18 and sedimentation velocity measurements 57 . These studies revealed that protofibrils are a population of aggregates with molecular weight distribution ranging from 80 kDa to ~1 mDa (ref. 23) .
Previous studies have established the ratio of Aβ40 to Aβ42 as an important factor in determining the fibrillogenesis, toxicity and pathological distribution of Aβ in vivo [58] [59] [60] . The ability to obtain monomeric and protofibril preparations of Aβ42 and Aβ40 by SEC allowed us to characterize the interactions between these two peptides at the levels of monomers, protofibrils and fibrils. This approach also enabled us to investigate how these interactions and changes in the relative ratio of Aβ42/Aβ40 influence Aβ oligomerization and fibrillogenesis in vitro. We showed that monomeric Aβ40 is a potent inhibitor of monomer Aβ42 amyloid formation at 1:1 ratio, whereas it inhibits fibrillization by Aβ42 protofibrils at substoichiometric amounts 21 . Furthermore, we found that Aβ42 protofibrils seed the fibrillization of monomeric Aβ42 but not of monomeric Aβ40. In contrast, fibrils composed of either Aβ42 or Aβ40 seeded the fibrillization of both Aβ42 and Aβ40 monomers 21 . Using these purified preparations, we were also able to show that monomeric Aβ42 and Aβ40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar Aβ aggregates 21 . Finally, using the same monomer and protofibril preparations referred to above, we dissected the mechanism by which the heat shock protein (Hsp104) interferes with Aβ oligomerization and fibrillogenesis. These studies revealed that Hsp104 inhibits Aβ fibrillization, targets different intermediates on the amyloid pathway and suppresses the seeding capacity of Aβ42 protofibrils and fibrils by blocking their growth 61 .
Identifying the toxic Aβ species and elucidating the mechanism of toxicity. A critical challenge in understanding the mechanism of Aβ toxicity, and in the subsequent design of intervention strategies, has been the correlation of a particular aggregate structure or size with biological effects, especially toxicity. Initially, fibrils were reported to be toxic, and inhibition of fibril formation or disruption of fibrils was considered to be a viable strategy for inhibiting Aβ toxicity [62] [63] [64] . Subsequent studies, using SEC-purified protofibrils and monomers, showed that protofibrils exhibit stronger toxicity than monomeric and fibrillar Aβ 14, 20, 21 . Together, these seminal studies showed that Aβ40 protofibrils consistently impaired neuronal metabolism 20 , instantly altered neuronal electrical activity and induced cell death 14, 21 . SEC-purified monomeric Aβ, in contrast, had no effect on neuronal electrical activity 14 and required 3-5 d of incubation to induce quantifiable cell injury 14 . This observation suggested that some aggregation intermediates, formed during the incubation of monomeric Aβ, were responsible for inducing toxicity. These findings were corroborated by studies in which cultured neurons were treated with monomers of highly amyloidogenic Aβ sequences, Aβ42 and Aβ40-Arctic. The results showed that the treated neurons exhibited loss of processes within 7 h and cell death within 13-24 h of incubation with monomeric Aβ42 and Aβ40-Arctic 65 . Similarly, using SEC-isolated Aβ42 protofibrils, we have shown that monomeric Aβ40 inhibited Aβ42 protofibril toxicity toward cultured neurons by altering their aggregation properties and inhibiting fibril formation. These observations reinforced the importance of an ongoing Aβ-nucleated polymerization as a critical factor for Aβ-induced toxicity 21, 66 . Size exclusion chromatography has also been used to characterize the relative toxicity of different Aβ protofibril preparations and has improved our understanding of the nature of toxic species in such preparations. ADDLs are soluble Aβ aggregates that, by atomic force microscopy, appear as spherical structures of 3-5 nm in diameter 15 . SEC was used to fractionate ADDLs and different fractions were compared for binding to the neuronal surface 67 . Results showed that void volume ( > 70 kDa) fractions selectively bound to the cell surface and processes of neurons. No such binding was reported for fractions containing monomers to tetramers, suggesting that advanced oligomer states, protofibrils, are more likely to be the culprit toxic species in ADDL preparation 67 . Subsequent solution-state characterization of ADDL preparations revealed that they consist of a heterogeneous population of Aβ species encompassing molecular sizes ranging from monomers to aggregates larger than 1 mDa, resembling the distribution observed for protofibrils.
In addition to sAβ oligomers, SEC has also been used to elucidate the nature of toxic Aβ oligomers obtained from natural sources. The conditioned media of Chinese hamster ovary cells, stably expressing Val-717Phe fAD mutation in APP, contain monomeric and LMW oligomeric forms of Aβ 68 . SEC was used to separate the monomers from oligomers and then fractions were used to assess the effects of both species on learning and memoryrelated tasks in rats. Intracerebroventricular injections into rats with fractions containing oligomers, but not monomers, were associated with significant errors in the behavioral performance of animals 69 . Transgenic (Tg 2576) mice, harboring the Swedish mutation in APP (APPSWE) linked to fAD, exhibit signs of memory deficits at the age of 6-14 months without accumulation of plaques or neuronal loss. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and SEC analysis of brain extracts from 6-to 14-month-old mice revealed that soluble multimers of Aβ, particularly a 56-kDa species and to lesser extent a 40-kDa species, correlated with the onset of memory deficit and remained stable during this time 70 . The 56-kDa species (Aβ*56) was then purified by SEC and injected into the lateral ventricles of young healthy rats. Assessment of spatial memory task performance revealed that Aβ*56 induced transient memory impairment in treated rats without affecting the learning of new tasks 70 . Thus, the use of SEC in the studies cited above allowed the investigators to selectively identify particular Aβ oligomers (dimers and trimers or Aβ*56) as the most likely cause of behavioral deficits observed in animal experiments.
Generation of novel tools and therapeutics. SEC-based methods, or information garnered from these methods, have also been useful for elucidating the mechanism of action of novel diagnostic and therapeutic approaches for AD. Immunizing rabbits with soluble oligomers of synthetic Aβ mimics resulted in the generation of an antibody that selectively reacted with Aβ oligomers in dot blot assays 71 . The antibody did not react with LMW or fibrillar preparations, suggesting conformation specificity for oligomers. SEC fractionation of Aβ oligomers and subsequent dot blot assay with an oligomer-specific antibody showed that the smallest oligomer size detected by the antibody corresponded to a 40-kDa protein 71 .
Interestingly, the antibody also showed binding to oligomeric preparations of other amyloidogenic sequences such as α-synuclein and human insulin, suggesting a molecular conformation shared by oligomeric intermediates of these proteins. Most importantly, the antibody was not only able to discriminate between AD-affected and normal brain but also distinguished thioflavin-S-positive (fibrillar) aggregates from non-thioflavin-S-binding (oligomeric) aggregates in AD-affected brain 71 . Similarly, immunization of mice with ADDLs led to the generation of monoclonal antibodies that selectively reacted with oligomeric SEC fractions of ADDLs and not with monomeric fractions. Immunostaining of brain sections or dot blots on brain extracts by these antibodies showed their ability to discriminate AD-affected from normal brain 72 .
Experimental design
The general procedure for isolating monomeric and protofibrillar Aβ fractions, and subsequent elucidation of their biophysical and biological properties, is outlined in Figure 2 . To prepare monomeric Aβ fractions, the lyophilized peptide is dissolved and disaggregated by guanidine hydrochloride treatment 65, 73 , and then the solution is injected into a suitable SEC column to separate Aβ monomers from guanidine ( Table 2) .
Aβ wild-type or mutant peptide Aβ solubilized
Centrifuged
Step 1
Step 2, Fractions collected (and concentration adjusted)
Step 3-14, Biophysical characterization This procedure yields fractions that are highly enriched (≥90%) in monomeric Aβ. Although these preparations are free of protofibrillar or fibrillar aggregates, the presence of unstable LMW oligomers (dimers, trimers, and so on) that are in rapid equilibrium with the major monomeric species has been suggested and cannot be ruled out. To prepare protofibrillar Aβ fractions, the peptide is initially dissolved in DMSO 57 and then aggregation is promoted under high-salt conditions. This leads to the generation of a solution enriched with Aβ protofibrils and monomers. The different aggregation states and monomers are separated on a suitable SEC column ( Table 2) . Often, these aggregation parameters can be assessed and customized by monitoring the degree of monomeric versus protofibrillar Aβ elution from the column. After a defined interval of incubation, if needed, the peptide solution is centrifuged to pellet out fibrils or insoluble material. The supernatant is then injected into a suitable SEC column capable of carrying out separation in a defined molecular size range, and Aβ species are eluted from the column under isocratic conditions. To avoid unwanted Aβ aggregation during the separation procedure, it is recommended that SEC fractionation be carried out using a chromatography system placed inside a cold (4 °C) chamber. Alternatively, SEC can be carried out at room temperature (RT; 20-25 °C) provided that Aβ solutions are kept at 4 °C before injection and immediately transferred to 4 °C after eluting from the column. Fractions are then assessed for protein content and subsequently used for biophysical and/or biological studies. Biophysical studies may include further separation by SEC, characterization of the kinetics of fibril formation (such as ThT binding) and the structural and morphological properties of aggregates by imaging techniques such as electron microscopy and atomic force microscopy. For biological experiments, SEC monomeric or protofibrillar fractions are diluted by the addition of cell/tissue culture (TC) components needed for maintaining the osmolarity, pH and nutritive value of the media. Monomeric and protofibril fractions at high concentrations (50-100-µM) are desired for these experiments. This can be achieved by scaling up the peptide preparation or using a modified or concentrated cell/TC media. Preparation of Aβ fractions at higher concentrations, by scaling up the amount of injected peptide, is possible only up to a certain concentration: 2-3 mg ml − 1 for slow aggregating Aβ sequences (e.g., Aβ40), but not for highly amyloidogenic Aβ peptides such as Aβ42 or the Arctic variant of both Aβ40 and Aβ42. At high concentrations of > 1-2 mg ml − 1 , the latter peptides start to fibrillize within minutes and precipitate, thus reducing the overall yield of monomers and protofibrils. Hence, a modified TC recipe for culturing primary neurons with concentrated components has been devised to minimize the dilution of Aβ fractions ( Table 3) . With tissue components added, various neurotoxicity studies can be conducted. Lactate dehydrogenase (LDH) release or MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assays can be used to measure overt cell loss (Step 17A) or histological staining for subtle morphological changes using cytoskeletal markers (Step 17B) can also be carried out. Electrophysiological measurements on cultured cells or brain slices were shown to provide a highly sensitive and instantaneous readout of neuronal abnormalities caused by the addition of specific Aβ aggregates, but require expensive equipment and specialized expertise, and will not be discussed in this paper 14 . Finally, biological activity can also be assessed in commercial cell lines of neuronal origin such as PC12 and SHSY5Y cells. In this case, modified commercial TC media (such as 10× Dulbecco's modified Eagle's medium) are commercially available and can be used to avoid further dilution of Aβ fractions.
Although SEC has been used to obtain monomeric and protofibrillar forms of Aβ, the yield of the respective fractions may vary depending on the peptide sequence and the presence of preformed seeds in lyophilized peptide stock. It is known that Aβ peptides from different manufacturers, or even different lots from the same source, may yield inconsistent aggregation and toxicity results 74 . The approach outlined in this protocol ensures that the recovered peptide fractions are free of any fibrillar material and variability among different Aβ preparations is minimized. Finally, to circumvent any potential problems associated with the use of sAβ peptides (such as impurities, racemization, salts or trace metals introduced during peptide synthesis and purification 52 ), many laboratories have developed methods for the expression of recombinant Aβ (rAβ) in E. coli [75] [76] [77] . rAβ peptides have been shown to exhibit similar or higher toxicity compared with sAβ 75, 76 . In addition to being free of any impurities associated with sAβ, which might interfere with aggregation or toxicity, rAβ peptides also offer an inexpensive means of obtaining radioisotope-labeled Aβ for structural studies using NMR 75, 76 . The present protocol, principally based on the use of SEC, describes methods for generating monomeric, protofibrillar and fibrillar forms of Aβ40 and Aβ42, using sAβ and rAβ peptides and fAD mutants (e.g., Aβ40-Arctic and Aβ40-Dutch) prepared with different counterions (trifluoroacetate (TFA) or sodium hydroxide) and obtained from different commercial suppliers and academic research groups.
MaterIals
REAGENTS
Human wild-type (wt) synthetic Aβ42-wt, Aβ40-wt and fAD mutants (Aβ40-Arctic (E22G), Aβ40-Dutch (E22Q) and Aβ40-Flemish (A21G)). These were synthesized and purified as TFA salts by Dr. James I. Elliott, WM Keck Facility, Yale University, New Haven, CT, USA, as previously described 78  crItIcal Aliquot the lyophilized peptide in glass vials, seal with a tight wrapping of parafilm and store the aliquots at − 20 °C. Before use, bring the peptides to RT by leaving the vial in a dry place for 10-15 min. Do not remove the parafilm wrapping except just before weighing and/ or solubilization (see Step 1 of PROCEDURE). It is recommended to store the vials in a box containing a desiccant (EM Sciences, cat. no. 71225-00) for this purpose. DMSO (Sigma, cat. no. 41639)  crItIcal DMSO is hygroscopic and should be stored in a dry place. Tris (hydroxymethyl)-aminomethane (Tris-base; Sigma, cat. no. T1503) Trizma hydrochloride solution (Tris-HCl, 1 M; Sigma, cat. no. T2663) Hydrochloric acid (32% (wt/vol) Merck, cat. no. 1.00319.1000) ! cautIon It is extremely corrosive and toxic and readily produces toxic vapors. Use a fume hood, face mask, eye protection and gloves while handling. Sodium hydroxide solution (NaOH, 1 N; Sigma, cat. no. 59223C) ! cautIon It is extremely corrosive and toxic. Use a fume hood, face mask, eye protection and gloves while handling. Guanidine hydrochloride (Gn-HCl; Sigma, cat. no. G4630) ! cautIon It is toxic and an irritant. Uranyl acetate (UA; Electron Microscopy Sciences, cat. no. 22400) ! cautIon It is a radioactive chemical, toxic if inhaled or ingested and it is categorized as a suspected carcinogen. Wear gloves, eye protection and face mask while handling. Thioflavin-T (ThT; Sigma, cat. no. T3516) Glycine (Sigma, cat. no. • .  pause poInt The columns should be equilibrated with at least two CVs or more (~50 ml for HR 10/30 columns) until a flat baseline UV signal is achieved. For carrying out Aβ fractionation, it is highly recommended to use a chromatography system placed in a 4 °C chamber. Alternatively, Aβ fractionation can still be carried out at RT, provided fractions are immediately transferred to ice (within 5-10 min of eluting from the column).  crItIcal For toxicity studies, the column is equilibrated with 70 mM NaCl + 10 mM HEPES (pH 7.4). The amount of NaCl used can vary from 0 to 70 mM as desired. Test the pH of the eluant to ensure that a pH between 7.2 and 7.6 is obtained. All Aβ preparations and column solutions used for cell culture experiments should be processed to maximize sterility. For storage and sterilization, columns should always be completely washed with 20% ethanol; for cleaning and sterilizing, the columns should be washed with 0.5 M NaOH solution (refer to the column data sheets provided by the manufacturer, for cleaning procedures). The columns can be operated at a higher flow rate (up to 1 ml min − 1 ), provided the maximum operational pressure, as recommended by the manufacturer, is not exceeded. , provided the maximum operational pressure, as recommended by the manufacturer, is not exceeded. Neuronal toxicity studies Obtain cortical neurons from E16 mouse embryos (Box 1). Add the cells in plating medium (Table 5 ) to poly-L-Lysine-coated glass coverslips or plastic 24-well plates (Box 2) at a density of ~2.5 × 10 5 cells per 0.4 ml per well. Place the plates in a cell culture incubator under conditions of high humidity, 37 °C and 5% CO 2 . On day 2, fully replace the media with neuronal growth media ( Table 5 ) and return the plates to the 37 °C incubator.  pause poInt Healthy cells should start to develop processes within 24 h of plating and interconnectivity should be observed 2-3 d after plating.  pause poInt This procedure leads to the formation of a mixture of monomer and protofibrillar Aβ42 in solution; however, the amount of protofibrils formed varies from 50-80% depending on the batch of the peptide and solubilization efficiency. To maximize the amount of protofibrils, incubate the solution at RT for 1-5 min. (iv) Carry out centrifugation and SEC fractionation as described in Steps 1A(ii-v) above.
 pause poInt Aβ protofibrils elute in the void volume (~7-9 ml of elution volume for HR 10/30 columns) and monomeric fractions elute similarly as mentioned in Step 1A(vi). (v) Combine the two fractions under void volume elution peak (7-9 ml of elution volume) and label as protofibrils. Separately combine the two fractions under elution peak at 11-13 ml (0. 6. Using a pair of sterile scissors and forceps, cut the abdominal skin along the midline and retract skin to the right and left side. 7. Rinse any fur from the abdominal muscles with 70% ethanol and use a second pair of sterile scissors to cut the abdominal muscles and peritoneum along the midline. Retract the abdominal walls to expose the uterus carrying the embryos, which will be readily observable. 8. Pull out the uterus after cutting the connective tissue and vasculature and transfer to a sterile 100-mm Petri dish placed on ice.  crItIcal step When picking out the uterus containing embryos, do not grab and puncture the intestines, which might pose a risk of infecting the embryos with bacteria.  pause poInt The intact uterus can be removed in a chain-like manner containing all embryos (on an average 8-12 embryos in a Swiss Webster mouse). In the following steps, transfer brain tissue to successive sterile dishes to reduce the possibility of bacterial contamination. 9. Dissect out the individual embryos by cutting open the uterus and amniotic sacks. 10. Using scissors, cut the head off at the neck region directly into the prepared 60-mm dish containing ice-cold dissection medium placed on ice. 11. Under a dissection microscope at ×2 magnification, cut the skin and the developing cranium (membranous and not calcified at this stage) along the midline.  crItIcal step Do not cut into the underlying neocortical surfaces.  pause poInt Less distortion of the brain increases the success of the microdissection. 12. With the brain exposed, scoop out the brain using fine forceps starting at the olfactory bulbs and moving posteriorly.  pause poInt A pair of forceps is used to disconnect the cranial nerves and lift the brain out as one moves posteriorly. The brain is removed intact and placed into the next clean 60-mm dish containing ice-cold dissection medium. Repeat this process for each of the remaining brains. 13. Transfer one brain into a 35-mm dish with ice-cold dissection medium and remove the meninges. The meninges (easily visible because of their vascularity) are removed as a continuous sheet by grabbing with the tips of the fine forceps and peeling over the front of the brain and then back toward the brainstem.  crItIcal step Removing the meninges is an important step to avoid fibroblast contamination of cultures. 14. Using forceps and starting at the fissure between the two hemispheres, roll out the medial part of one hemisphere to reveal the hippocampus.  pause poInt The hippocampus is at the medial interface of the upper surface of the neocortex and appears as a rostral-caudal curved tubule. 15. Using fine forceps, cut along the neocortex-hippocampus interface and remove the hippocampus.  pause poInt The hippocampus removed at this stage can be used to prepare hippocampal cultures. 16. With the hippocampus removed and the neocortex rolled a little further laterally, cut with the fine forceps at the underlying neocortex (light, lateral area)-striatum (dark, medial, striated structure) interface. Repeat this step for each side and place the two cortical hemispheres into new 35-mm dishes with ice-cold dissection medium.  pause poInt The process of isolating each cerebral cortex from each brain is continued and all hemispheres are combined. 17. Carefully remove as much of the dissection medium as possible and then add 1 ml of Trypsin-EDTA, mince with forceps and incubate for 10 min at 37 °C to activate Trypsin.  pause poInt Trypsin is kept cold before addition to minimize self-inactivation. In addition, Trypsin is frozen as 1-ml aliquots, allowing only the amount needed to be thawed for each dissection.  crItIcal step The repeated freezing and thawing of Trypsin, especially at 37 °C, will continually reduce the effectiveness of this protease. 18. While trypsinizing tissue, narrow the opening of a sterile glass Pasteur pipette by flaming the tip.  crItIcal step Do not narrow it too much. 19. Slowly triturate the trypsin-containing cortices through the pipette until a homogenous suspension is achieved. 20. Transfer the triturated tissue (should be around 1 ml) to a sterile 15-ml tube and add 1 ml of plating medium containing serum to inhibit the trypsin. The tissue and medium solutions are mixed with the trituration pipette. , based on the total weight of the peptide) in 1 mM NaOH plus sterile phenol red (0.1 mg ml − 1 to monitor the pH of the solution). The final pH of this solution is ~3.  crItIcal step By careful visual inspection, ensure that no precipitates are present and that all of the lyophilized peptide has been dissolved in the solvent.  pause poInt The vial/tube with the peptide can be centrifuged (3,000g at RT for 1 min) before solubilization to bring the lyophilized peptide to the bottom of the vial/tube and minimize peptide loss.
(ii) Add 140-155 µl of 10 mM NaOH per mg of peptide.
 crItIcal step To minimize isoelectric precipitation of Aβ (pI ~5.5), which can vary between manufacturers and specific lots, 10 mM NaOH is added to achieve a rapid transition to a pH of ~7.0-7.5. This can be visualized by orange to red color change, when phenol red is used as the pH indicator.  pause poInt Additional acid or base can be added to achieve the proper pH. , with the individual fraction size being 1 ml.  crItIcal step Set upper pressure limit to 1.5 MPa.
(iii) Collect four 1-ml fractions, corresponding to the elution volume of 6-11 ml, which contain the total protofibril peak, and do not combine. The monomer fractions (elution volume 14-16 ml) can be combined.  crItIcal step Immediately transfer the fractions to ice or keep at 4 °C, but do not freeze or leave at RT (if SEC is carried out at RT).  pause poInt Fractionation efficiency can also be increased by connecting two SEC columns in series (such as two Superose 6 HR 10/30 columns or a 21 . Count the cells using a hemocytometer.  pause poInt Cells can be incubated with trypan blue before counting to determine the ratio of live to dead cells. Trypan blue is excluded from viable cells. 22. Finally, dilute the cells for plating in the plating media (table 2) at a density of 2.5 × 10 5 cells per 0.4 ml per well, then add to poly-l-lysine-coated 24-well plates or poly-l-lysine + laminin-coated coverslips (box 2). Place plated cells into an incubator at 37 °C. TSK4000 SEC column connected in series to Superose 6 HR 10/30). However, in the latter case, to obtain Aβ fractions at concentrations above 20 µM, 1.5-2 mg ml − 1 peptide should be solubilized for fractionation.
Box 1 | CoNTINUED
concentration determination 2|
The protein concentration of the fractions can be determined by different methods depending on the instrumentation available and desired accuracy. Aβ concentration can be determined by measuring absorbance at 280 nm using a UV spectrophotometer or any of the commercially available protein assays (such as BCA assay). Both of these methods are readily available, but may contain marginal error. For measurements requiring high precision, amino-acid analysis (AAA) is recommended. The latter method requires sending the samples to a specialized facility, and requires a few hours/days to complete. If information regarding the absolute concentration of Aβ fractions is critically needed, we recommend using one of the methods described below to determine the concentration for short-term reference, and sending some of the original solution for AAA. If the concentration determined by AAA is different from that determined by UV or BCA, the latter is then corrected accordingly.
We have carried out a comparison of these methods for measuring Aβ concentrations and the findings are summarized in box 3. box 3 also contains some assay-related information for UV A 280 nm and BCA, in the context of Aβ concentration estimations.
(a) using uV spectrophotometry • tIMInG ~10 min (i) Stabilize the light source of the spectrophotometer by turning on the lamp for ~10-15 min before its use. Obtain the UV absorbance of SEC running buffer (10-mM Tris-HCl (pH 7.4)), at wavelength (λ) 280 nm (A 280 ), by placing 100 µl of the buffer in a 10-mm-path-length cell. Set the reading of the spectrophotometer to zero using the unadulterated running buffer. Thereafter, obtain UV absorbance at λ280 nm for the different Aβ fractions. 
Box 2 | CoATING CoVERSLIPS AND 24-WELL PLASTIC PLATES
Neurons are plated onto either 24-well plastic plates for biochemical evaluation of cell viability or onto glass coverslips for histological observations. 1. Sterilize coverslips with 100% ethanol for a minimum of 2 h or overnight in a sealed sterile dish.  crItIcal step Do not use 70% ethanol, which will lead to coverslips being difficult to separate and potential breakage. 2. After sterilization, suction off ethanol and air-dry the coverslips in a sterile environment (e.g., in a TC hood). 3. Place one coverslip per well; a 12-mm coverslip fits into the well of a 24-well plate.  crItIcal step Low evaporation plates are necessary to minimize the liquid loss in the outside wells. 4. Prepare substrate solution to coat glass coverslips by combining poly-l-lysine (PLL) (MW 331K) + laminin solution. To obtain 10 ml of substrate solution, add 1 ml of PLL solution (1 mg ml − 1 ) and 0.1 ml of laminin solution (1 mg ml − 1 ) to 8.9 ml sterile, high-quality water.  pause poInt Laminin is not needed if coating is carried onto plastic surfaces. 5. Add 300 µl to each well containing a coverslip (requiring 7.2 ml per 24-well plate). Wrap plates in aluminum foil and incubate overnight at RT. 6. Next day, wash plates three times with sterile water and then air-dry in TC hood.  pause poInt Plates that are not used immediately can be stored at 4 °C, properly wrapped in aluminum foil. 
Box 3 | CoMPARISoN oF UV A 280 nm , BICINCHoNINIC ACID (BCA) ASSAY AND AMINo-ACID ANALYSIS (AAA) FoR DETERMINATIoN oF A CoNCENTRATIoN
We have outlined two commonly available methods of protein concentration determination, namely UV A 280 and BCA, in Step 2 of this protocol. However, the following points are worth mentioning in the context of Aβ concentration estimations: 1. UV A 280 : The method relies on the molar absorbance coefficient for a particular protein (box 4). Theoretically, the concentration of monomeric protein can be reliably assessed; however, the concentration of protofibrils contains a marginal error (as protofibrils do not have the same molar extinction coefficient as monomer). Therefore, another assay such as BCA can be used to increase the reliability of protofibril concentration determined by UV A 280 . In addition, we have also observed that Aβ concentrations below ≤20 µM are underestimated by the UV A 280 method than by BCA (see below). The most likely reason for this is the scarcity of aromatic residues in the Aβ amino-acid sequence. 2. BCA: The majority of commercial kits for determining protein concentrations (such as the PIERCE BCA kit) include BSA for generating a standard curve. The concentration of protein in unknown samples is determined using this standard curve. We found that a BSA standard curve results in ~40-50% underestimation of Aβ concentration in the fractions, compared with a standard curve based on Aβ40 serial dilutions (supplementary Fig. 4b) . Moreover, there was close correlation between Aβ concentration estimations by two assays, when we used a standard curve based on Aβ40 serial dilutions. Therefore, we encourage the use Aβ40 standard curve for Aβ concentration estimations and not BSA. In contrast to Aβ42, Aβ40 is soluble in many aqueous media and less prone to aggregation. A 200-µM Aβ40 stock solution can be used for 10 serial dilutions (5-200 µM) with only ~200 µl of Aβ40 stock needed for one assay. Accordingly, repeated freeze and thaw cycles can be avoided by aliquoting the stock solution (200 µl per aliquot) and thawing it on ice. Freezing and thawing Aβ may also introduce unwanted artifacts and interfere with the protein determination. To address this, we also carried out BCA assay on Aβ40 solutions, which were either freshly prepared or aliquoted and frozen. Data show that both fresh and frozen Aβ40 solutions yield comparable results by BCA (supplementary Fig. 4c) Figure 4a . Briefly, (i) BCA measurements were found to be ~10-20% higher than UV measurements (Aβ40 standard curve was used for BCA); and (ii) UV A 280 measurements were ~10% higher than AAA measurements. This applied to both monomeric and protofibrillar fractions.  pause poInt Protofibrillar fractions can also be analyzed by injection into a Superose 6 pc 3.2/30 column. The elution of protofibrils on a Superdex 75 pc 3.2/30 column provides a measure of protofibrillar content rather than size distribution. In contrast, on a Superose 6 pc 3.2/30, protofibrils elute as a broad peak in the void volume + included volume, thus allowing for analysis of heterogeneity and progression of aggregation.
4|
Elute the fraction at a flow rate of 0.05 ml min − 1 for 60 min.  crItIcal step Set the high pressure limit to 2.4 MPa (Superdex 75 pc 3.2/30) or 1.2 MPa (Superose 6 3.2/30).  pause poInt Although the PDA detector monitors sample elution at a range of wavelengths (200-400 nm), for analytical purposes, A 210-214 nm is adequate. Samples can also be eluted at flow rates of up to 0.1 ml min − 1 , provided the maximum pressure limit recommended by the manufacturer is not exceeded. ? troublesHootInG Morphological characterization by teM • tIMInG ~20 min for one sample 5| Deposit 2-10 µl of a sample containing Aβ on a formvar-coated TEM grid and let the sample droplet settle for ~60 s.  crItIcal step Place Aβ samples on TEM grids as soon as possible after fractionation to be able to assess the aggregation state of the starting material.  pause poInt If the sample is ≥20 µM, deposit between 2 and 5 µl; for samples < 20 µM, deposit 5-10 µl. The grids can also be glow discharged, which improves subsequent sample deposition on the surface.
6|
Remove excess solution by wicking the edge of the grid on a piece of blotting paper.
7|
Deposit a 10-µl drop of 2% UA on the grid and let it settle for ~60 s 8| Remove excess solution by wicking the edge of the grid on a piece of blotting paper.
9|
Gently vacuum dry the grid from the edges.  crItIcal step Do not touch the grid with vacuum probe to avoid physical damage to the grid. Use the vacuum to produce an air current over the grid to evaporate the remaining liquid.  pause poInt Grids can be placed in a storage box in a dry place. Storing in a desiccating chamber or box will help prevent moisture accumulation and sample degradation.
10| Acquire images on a CM10 TEM (or equivalent TEM), equipped with a CCD camera, operated at an acceleration voltage of 80-100 kV. ? troublesHootInG assessment of fibril formation kinetics by tht binding • tIMInG ~10 min for one time point 11| For fibrillization studies, aliquot 350-500 µl of each Aβ fraction into two 1.5-ml sterile microtubes.  crItIcal step The sample volume should be ≥300 µl in a 1.5 ml polypropylene sterile microtube. Smaller volumes generate more errors during different aggregation experiments. Tubes larger than 1.5 ml also pose a problem because of increased evaporation.
12|
For ThT-binding measurements, mix 80 µl of 10 µM Aβ fraction with 10 µl of 100 µM ThT and 10 µl of 500 mM glycine-NaOH (pH 8.5) in one well of a 384-well black plate.  crItIcal step Avoid generating air bubbles as they will interfere optically with fluorescence signal acquisition.  pause poInt This step is described for a final concentration of Aβ of ~10 µM, a ThT:Aβ ratio ≥1 and a final glycine-NaOH concentration of 50 mM. The step can be modified to accommodate different concentrations of Aβ. For example, for a sample of 50-µM Aβ, either dilute the sample with sample buffer to 10-µM and proceed as above or use 70 mM glycine-NaOH stock-solution (20 µl Aβ + 70 µl glycine-NaOH + 10 µl ThT (100 µM)). Each sample should be assayed at least twice.
13| Acquire ThT fluorescence values using an Analyst AD fluorometer or a comparable fluorescence plate reader using an excitation wavelength of λ450 nm and an emission wavelength of λ485 nm. (table 6) . Cultured neurons are exposed to various Aβ aggregates by removing all the media and adding 0.4 ml per well of the SEC fraction mixed with modified neurobasal media.  pause poInt The eluate from the SEC will not sustain the viability of the cultured brain cells. Therefore, TC components need to be mixed with SEC fractions to correct sodium and potassium levels, provide energy and provide the correct pH. Standard TC medium can be purchased, but SEC fractions might be low in Aβ concentration, thus necessitating minimal further dilution of the SEC fraction by TC media. To accommodate this, modified neurobasal media are used to add TC components in minimal volumes (table 3) . Neurobasal medium was developed to specifically support neurons 79 . Using this formulation, TC components can be varied for experimental purposes. The TC components should be added to SEC fractions shortly before application to cells.
14|
16|
Remove media from neuronal cultures and replace with Aβ fractions containing TC components and place the cells back in a 37 °C incubator with 5% CO 2 .
17| After 1 h to 5 d, assess the effects of Aβ treatment on neurons using biochemical methods such as LDH release assay and/or immunocytochemistry methods. LDH is a cytosolic enzyme that is primarily released on loss of integrity of the cell membrane and is a reliable indicator of cell death. The LDH release is proportional to the number of dead cells that can be measured in the culture medium. Alternatively, neurons plated on glass coverslips can be fixed and stained with antibodies to detect changes in neuronal architecture. The LDH release assay cannot detect cell loss, nor can it detect minor structural changes that may have important repercussions for the function of the neuron. Loss of synaptic connections would render a neuron as dysfunctional as neuronal death. The antibodies used here can also distinguish between changes in the dendritic (MAP2) versus axonal (NF-M) compartments. (a) lDH release assay to determine cell death (i) Prepare 100 ml of buffer by adding one buffer tablet to 100 ml of distilled water.
(ii) Prepare LDH diaphorase solution by adding 150 µl of buffer and placing it on ice.  crItIcal step Extra solution can be frozen, but aliquoted to go through only one freeze-thaw cycle. (iii) Prepare LDH reaction solutions by adding 100 µl of the following four components to 9.6 ml of buffer. Include a zero concentration by adding 100 µl of the buffer prepared in the first well.  crItIcal step If serum is used in an experiment, it will contain LDH and could interfere with the assay. (vii) Remove 100 µl of the medium from the experimental wells and transfer to the plate containing standards. (viii) Using the reaction solution prepared in Step 17A(iii), add 100 µl to each of the standard and experimental wells.
(ix) Shake for 30 min at RT. Using a 96-well microplate reader (TECAN safire 2 or any other suitable microplate reader), measure absorbance at λ490 nm. A standard curve of the LDH activity versus absorbance can be generated. The absorbance of the experimental sample can be used to determine LDH activity.  pause poInt The standard curve should be linear in the range of standards and the experimental samples should fall into this range. If not, higher samples must be diluted to bring them into the linear range of the standard curve.  pause poInt The assay is based on Cayman Chemical Company's LDH assay and is outlined for measuring all wells in a 96-well plate. The assay for all standards and samples should be carried out either in duplicate or in triplicate. If more than one plate is needed, it is recommended to add standards to all plates that are being used.  pause poInt Antifade reagent helps suppress photobleaching. Coverslips are allowed to dry overnight, whereas plates can be assayed directly.  pause poInt Cultures can be visually monitored to determine when the experiment should be stopped depending on the response(s) of interest (for example, neuronal changes versus cell death). Small volumes of the medium can be tested from living cultures to determine whether cell death is occurring (such as by the release of LDH (Step 17A)). If the morphological changes in neurons are important, the entire medium at that time point is collected and the neurons are immediately fixed and stained (Step 17B). Morphological changes can be seen using the Aβ40-Arctic peptide as early as 5 h, whereas Aβ40 wt peptide-induced cell loss could require 3-5 d.
? troublesHootInG Troubleshooting advice can be found in table 7. antIcIpateD results This paper describes a step-by-step method, principally based on SEC, for generating preparations of Aβ monomers and protofibrils, as well as fibrils, from various Aβ peptide sequences. This method has been used extensively by our group and by many other researchers in the field to elucidate Aβ amyloid formation, investigate the nature of the toxic Aβ species and develop amyloid-based diagnostic tools and therapeutic strategies for AD. This paper provides a convenient reference for the AD research community for reliable preparation and isolation of these different Aβ aggregate states for structural and functional studies.
preparation and characterization of monomeric a
Fractionation. Lyophilized Aβ peptides, obtained from different sources, are easily solubilized using 6-M guanidine hydrochloride, and the resultant solution contains predominantly monomeric Aβ (Fig. 3) . Insoluble preexisting aggregates, if present, are effectively removed with brief centrifugation (≥16,000g, ~10 min). When this guanidine hydrochloride solution of Aβ is injected into a Superdex 75 HR 10/30 SEC column, the peptide elutes as a single peak in the included volume of SEC column (0.45-0.55 CV for Superdex 75 HR 10/30; elution volume 11-13 ml) corresponding to predominantly monomeric Aβ (Fig. 3a-red line) . Generally, 1 mg of Aβ40 or Aβ42 (~80% net weight) dissolved in 1 ml of guanidine hydrochloride yields ~2 ml at final concentrations of ~50-80 µM. Previous translational diffusion measurements of these Aβ elution fractions, by pulse field gradient solution phase NMR, showed that Aβ predominantly elutes as a monomer 80 . The presence of a small amount of LMW oligomers (dimers, trimers, and so on), which exist in rapid equilibrium with the monomer, has been suggested and cannot be ruled out 53, 73 . However, these oligomeric species do not seem to accumulate or exist in stable forms, unless stabilized by chemical crosslinking 17 . characterization. Reinjection of purified monomers into a Superdex 75 pc 3.2/30 SEC analytical column showed a single elution peak and confirmed that the fractions corresponded to monomeric (M) Fig. 3b red line; peak around ~26 min) . TEM analysis of monomeric fractions, soon after fractionation, confirmed the absence of any aggregated Aβ in these preparations (Fig. 3e) (monomeric Aβ is not detectable by TEM). Circular dichroism (CD) analysis followed by spectra deconvolution using CCA + software Lincomb algorithm 81, 82 was carried out to assess the secondary structure elements of the Aβ fractions. CD analysis of this preparation showed a spectrum with minima at ~195-205 nm, consistent with a predominantly random coil conformtion (supplementary Fig. 1a) . Deconvolution of the spectrum suggested a mixture of predominantly (60%) random coil conformation and 39% β-turn structure. SDS-PAGE and the subsequent silver staining and/or western immunoblotting with 6E10 antibody showed that SEC-isolated monomeric Aβ40 migrated as a single band. In contrast, monomeric Aβ42 fractions migrated as a mixture of monomers, dimers and trimers, with monomer being the predominant species under similar conditions of electrophoresis (supplementary Fig. 1b) . Previous studies have suggested that this anomalous migration of Aβ42 on SDS gels is a result of SDS-induced Aβ oligomerization because of the effect of SDS micelle formation and high local concentration of Aβ in micelles 73 . In addition, it is also possible that Aβ42 at higher than critical concentrations, and because of its high aggregation tendency, exists in equilibrium with LMW oligomers (dimers, trimers and low n-mers) seen on the gels 53, 73 . Briefly, the SEC method outlined above ensures that the starting material of the experiment is predominantly monomeric Aβ, free of protofibrillar or fibrillar aggregates and can be obtained in solutions free of organic solvents and compatible with cell culture manipulations. The extent of oligomerization and the amount of LMW oligomers formed is strongly dependent on the Aβ peptide sequence, the Aβ concentration and the incubation temperature and time. Therefore, we recommend the immediate use of SEC fractions or the maintenance of samples at 4 °C until use. Although we have not observed significant protofibril formation by TEM and ThT binding, when these solutions are stored at 4 °C for up to 24 h (supplementary Fig. 3c,i) , we cannot rule out that the oligomerization and formation of LMW oligomers take place under these conditions. This is especially critical when Aβ42 and Aβ42/Aβ40-Arctic mutant (E22G) are used and stored at concentrations > 50 µM. Therefore, we recommend that peptide solutions be prepared freshly before performing the experiments, maintained at 4 °C and used within a few hours ( < 3-5 h). If the experimental setup and conditions do not allow for rapid preparation and the immediate use of the monomeric Aβ fractions, we recommend that the samples be stored at 4 °C. To ensure the absence of fibrillar or protofibrillar aggregates at the time of using a stored sample, a small aliquot can be centrifuged and evaluated by Ana-SEC, ThT and TEM.
preparation and characterization of a42 protofibrils Fractionation. To generate protofibrils of Aβ42, or Aβ sequences with a high aggregation tendency (like Aβ-Arctic), the peptide is solubilized using the DMSO method 18 ( Step 1B). This method is very effective in yielding a solution enriched with protofibrils of broad size distribution 18 ; however, this preparation also contains a significant amount of monomeric Aβ that must be separated from the protofibrils. Fractionating this preparation on a Superdex 75 HR 10/30 SEC column yields two elution peaks separated by ≥2 ml of elution volume. The first peak corresponding to the void volume (~7-9 ml of elution volume for the HR 10/30 columns) is enriched with protofibrils (PF), whereas the second elution peak corresponds to monomeric (M) Aβ42 (Fig. 3a, black line) . When 1 mg of Aβ42 (~80% net weight) is solubilized using the DMSO method (860 µl of total solution) and fractionated as mentioned, the typical yield is as follows: PF ~2 ml, ~40-60 µM of final Aβ concentration and M ~2 ml, ~40-50 µM of final Aβ concentration.
reproducibility of fractionation. Generally, when Aβ42 is solubilized in DMSO and fractionated, the PF peak area and height are almost always greater than the M peak, but the absolute values are not identical from one injection to another. To illustrate this, analysis of Aβ42 protofibrillar preparations (using the DMSO method), carried out by three different individuals in our group over the past 2-3 years, is presented in Figure 3c . The data show that there is occasional variation between the extent of PF and M elution. For each injection, the combined (PF + M) peak area was expressed as 100%. The percentage (%) mean peak area for PF and M elution was calculated and the results confirmed that the usual trend of Aβ42 elution is PF > M (the mean peak area ratio of PF to M = 52:48; % s.d. from mean: PF = 0.8-18, M = 0.1-13; n = 25). For Aβ40 or other lessaggregation-prone Aβ sequences, the M elution almost always predominates (supplementary Fig. 1f ). Despite these slight variations, structural analysis of Aβ42 PF and M fractions did not exhibit any drastic differences (data not shown). However, these different elution patterns produce variations in the concentration of Aβ fractions.
characterization. Protofibrils were obtained as described above and subjected to further analysis. TEM analysis of the protofibril fractions showed aggregates of various morphologies including curvilinear aggregates ( < 200 nm long) and small spherical structures (Fig. 3g) . These observations were consistent with previously described morphologies for protofibrils 12, 13 . Protofibrils, on reinjection into an Ana-SEC (a Superdex 75 pc 3.2/30 column), elute predominantly in the void elution volume (Fig. 3b , black line; peak height around ~19 min). Interestingly, in addition to void volume elution, we consistently observe an additional small peak corresponding to the monomer elution. This could be due to either the reestablishment of monomer-protofibril equilibrium, monomer dissociation due to interactions with the chromatography matrix or a combination of both. To determine whether this monomer peak was consistent and also whether there was a variation in this peak from one protofibril preparation to another, we carried out statistical analysis of 20 Ana-SEC elution profiles of Aβ42 protofibrils. The analysis was based on reinjection of purified protofibrils on independent occasions and using different preparations. For each reinjection, the combined (PF + M) peak area was expressed as 100% and the percentage (%) mean peak area for PF and M elution was calculated. The data presented in Figure 3d show that SEC-purified protofibrils, when reinjected into a Superdex 75 pc 3.2/30 column, predominantly elute in the void volume, with a small elution peak corresponding to monomeric elution (mean peak area PF:M = 79:21; % s.d. from mean: PF = 0.95-14, M = 0.05-13; n = 20).
The fractions were then subjected to CD spectroscopy for analysis of secondary structure elements. CD spectra deconvolution, carried out using the CCA + software Lincomb algorithm 81, 82 , showed that the protofibrils, obtained using this protocol, consisted of 43% β-sheet, 38% α-helix and 5% random coil as secondary structure elements (supplementary Fig. 1a) . These values for the secondary structure elements were similar as reported previously for Aβ40 protofibrils and show that protofibrils consist of mixed α-helical-β-sheet structural elements 14, 20 . Similar to protofibrils of synthetic Aβ40 (ref. 14) , Aβ42 protofibrils are SDS-labile and run as multiple bands (monomer to trimer), along with a high-molecular-weight smear, by SDS-PAGE (supplementary Fig. 1b) , despite the fact that these species elute in the void volume of Superdex 75 ( > 70 kDa), which should only contain PFs. This anomalous migration on SDS gels by protofibrils and oligomers of sAβ has also been reported by other groups 13, 83 . There are different possibilities to explain these experimental observations; (i) some of these LMW oligomers may exist in rapid equilibrium with protofibrils; (ii) these oligomers may not exist in solution but form as a result of SDS-induced disassociation of protofibrils; or (iii) formation of these species may be induced by the interaction of Aβ with SDS micelles as described above 73 . SDS-stable Aβ oligomers have been consistently observed in naturally secreted Aβ preparations obtained from the conditioned media of Chinese hamster ovary cells, overexpressing wt APP or APP-bearing fAD mutations 19, 55 . These species migrate predominantly as dimers and trimers on SDS-PAGE and have been proposed as bona fide oligomers 19 . However, these species are distinct from the oligomeric forms described above, because they were shown to be stable and did not disassociate after treatment with formic acid, heating or incubation with chemical denaturants (guanidine hydrochloride). Furthermore, naturally secreted oligomers have not been shown to undergo further oligomerization and fibril formation. Although chemical modifications and/or covalent cross-linking of monomeric Aβ species could explain the kinetic stability and lack of fibrillization by these oligomers, direct evidence for such modifications by mass spectrometry or by other tools remains lacking.
Fibrillization studies
To study the aggregation and kinetics of fibril formation, purified Aβ42 PF and M fractions were separately incubated (~10 µM) at 37 °C without agitation and allowed to fibrillize. Consistent with previous reports 13 , we observed that PF fractions showed a less pronounced rise in ThT binding over time, compared with M fractions (supplementary Fig. 1c) . TEM analysis, after 96 h of incubation, revealed that although in the case of monomeric fraction elongated intertwining fibrils were formed (Fig. 3f) , the PF fraction contained a substantial amount of elongated protofibrils interspersed among fibrils (Fig. 3h) . The slow fibrillization of protofibrils is consistent with the proposed mechanism of fibril formation by monomer addition, rather than annealing and/or self-assembly of protofibrillar aggregates 20, 21 . Indeed, addition of monomeric Aβ to protofibrillar fractions accelerates their fibrillization 21 .
preparation and characterization of a40 protofibrils
Aβ40 protofibrils can be generated in a consistent manner by dissolving the peptide in NaOH and rapidly moving the highly acidic TFA salt peptide through its isoelectric point to a pH of 7.2 − 7.6 (ref. 14). Incubating the peptide at 500 µM in PBS (pH 7.4) for 2-3 d at RT generates monomers and protofibrils, which vary around a PF:M ratio in the range of 40-60% (ref. 14) . The progression of protofibril formation can be quantitatively monitored on a daily basis by injecting small aliquots of the stock solution into a Superdex 75 HR 10/30 SEC column or into an analytical Superdex 75 pc 3.2/30 column. Before injecting into an SEC column, the sample is briefly centrifuged (16,000g for 10 min at 4 °C) to remove any fibrils that might have formed during the incubation. This is usually indicated by the appearance of a pellet after the centrifugation. TEM analysis of the pellet obtained in this procedure revealed that they are predominately made of fibrils 14 . Regarding the SEC elution profile, the protofibril peak appears first in the void volume (~7-9 ml for HR 10/30 columns) and can be collected in 0.5-1-ml fractions with Aβ concentrations ranging from 10 to 40 µM. TEM images of this protofibril peak showed small spheres, ~4-6 nm in diameter with a variation in length, and curvilinear structures < 200 nm in length and ~4-6 nm in width 14 . The CD spectrum of these fractions showed a broad negative ellipticity between 225 and 208 nm, consistent with the presence of a mixture of random coil, α-helix and β-sheet structures 14 . Estimation of the secondary structure contents of the CD spectra, performed using the CDANAL program 82 and the Brahms and Brahms reference library 84 , showed that these protofibril preparations contain 47% β-sheet, 40% random coil and 13% α-helix secondary structure elements 20 . In addition, the protofibril peak was found to bind Congo red and ThT similarly, but to a lesser extent, than mature fibrils 14, 20 . The protofibril fractions can be combined (~1-2 ml) or analyzed separately depending on the concentration of peptide and solution volume needed. The monomer peak emerges in the included volume, as mentioned above, and can yield similar concentrations as the protofibril peak. TEM analysis of monomer fractions confirmed the aggregate-free nature of the preparation 14, 20 . SDS-PAGE, followed by western blotting analysis, for monomer fractions, showed a single 4-kDa band; however, the protofibrillar fractions migrated as a mixture of multiple bands with molecular weights corresponding to species from monomer to tetramer 14 . The latter observation suggested that Aβ40 protofibrils were not SDS stable and migrated as LMW bands on SDS gels. application to a faD mutants The methods described above for wt Aβ (Aβ40 and Aβ42) solubilization and fractionation are also useful for preparation of different monomeric and protofibril fractions of fAD Aβ mutants. We have used this protocol to isolate the monomeric and protofibrillar forms of Aβ40-Arctic (E22G), Aβ40-Dutch (E22Q) and Aβ40-Flemish (A21G) peptides. Figure 4 summarizes the results of these studies. Aβ40-Arctic (E22G) exhibits faster aggregation kinetics than does wt Aβ40 and has a higher tendency to form and accumulate protofibrils 18, 36, 85 . Accordingly, we found that dissolving synthetic Aβ40-Arctic in DMSO (Step 1B) resulted in a solution that is highly enriched with protofibrils and monomeric Aβ. Fractionation of this solution on a Superdex 75 HR 10/30 column showed that the predominant elution peak was in the void volume (Fig. 4a, black line) and contained aggregates of heterogeneous morphologies including curvilinear and spherical assemblies (Fig. 4e) . The fibrillization studies revealed that Aβ40-Arctic formed high ThT-binding fibrils, both from solution containing monomeric or protofibrillar Aβ40-Arctic (Figs. 2h and 4b , only fibrils from the monomeric fraction are shown). Using the DMSO solubilization method, the yield of Aβ40-Arctic is similar to that of Aβ42 protofibrils (2 ml; ~40-60 µM). Previous efforts to generate Aβ40-Arctic protofibrils, using the NaOH solubilization method, resulted in only 10-40 µM for similar volumes 18 . Therefore, we recommend using the DMSO solubilization method (Step 1B) for generating Aβ40-Arctic protofibrils. The Aβ40-Dutch (E22Q) mutant exhibited a similar SEC elution pattern as the wt Aβ42 (Fig. 4a, red line) ; however, these protofibrils formed fibrils only at concentrations ≥20 µM (Figs. 2i and 4c) . Finally, Aβ40-Flemish (A21G) also eluted as two peaks corresponding to a protofibrillar and monomeric species (Fig. 4a, green line) , but neither was shown to form fibrils over the time course of the experiment (96 h incubation at 37 °C, without agitation) (Figs. 2j and 4d) . These observations are in accordance with previously published reports showing that Arctic (E22G) and Dutch (E22Q) mutations in Aβ significantly increase fibril nucleation and growth, whereas the Flemish (A21G) mutation decreases fibril growth 85 . application to ra peptides and synthetic peptides from other sources Next, we sought to determine whether this protocol for generation of monomeric and protofibrillar Aβ fractions is equally applicable to synthetic (sAβ) and recombinant forms (rAβ) of Aβ obtained from different sources. For this purpose, we obtained synthetic Aβ42 (as TFA salt) from Bachem (Switzerland, cat. no. H-1368). rAβ peptides were purchased from a commercial source (rPeptides, Bogart, GA, USA) and were also donated generously by two independent research groups (Carl Frieden, Washington University, St. Louis, USA and Rudolf Glockshuber, ETH, Zurich, Switzerland). Further, the rAβ42 peptides from rPeptides were provided as either TFA (cat. no. A-1002-2) or NaOH (cat. no. A-1165-2) salts, thus allowing us to determine whether different counterions affect the extent of protofibril formation. All sAβ and rAβ peptides were solubilized using the DMSO method and fractionated on a Superdex 75 HR 10/30 column. Synthetic and recombinant Aβ42 eluted as protofibrillar and monomer peaks (Fig. 5a,b) , and TEM analysis of the protofibrillar fractions showed predominantly curvilinear and spherical morphologies (Fig. 5c-f) . Recombinant Aβ40 peptides also eluted in an identical manner as synthetic Aβ40 (Keck facility), as a predominant single elution peak in the included volume and as a small peak in the void volume (supplementary Fig. 1f-g ). These observations show that the protocol outlined above is applicable to Aβ peptides from synthetic and recombinant sources. However, it is noteworthy that protofibrils are a heterogeneous population of aggregates and it is quite likely that the size distribution among protofibrils might not be identical for Aβ prepared in different methods (synthetic and recombinant).
subfractionation of a42 protofibrils and aggregated a42
Further separation of protofibrils of different sizes can be achieved using columns with different separation capacities or combining multiple columns with extended separation ranges (table 2) (for example, the Superose 6 HR 10/30 column by itself (supplementary Fig. 2 ) or a Superose 6 HR 10/30 column connected in series to a TSK-GEL 4,000 SEC column). Generally, this procedure yields from four to six protofibril fractions (1 ml each), but only the first and last fractions differ significantly in terms of size and morphology distribution. For example, we previously showed that fractionation of the protofibril peak, obtained from a 1:1 solution mixture of Aβ-Arctic and Aβ40 wt, using a Superose 6 column, yielded seven protofibril fractions 18 . Only fraction 7 was highly enriched in annular Aβ structures, with a molecular weight distribution centered around 150-250 kDa. The remaining fractions were heterogeneous and exhibited a molecular weight distribution of 80-880 kDa 18 . We have observed that the addition of monomers of a slow aggregating sequence (e.g., Aβ40) to a highly amyloidogenic sequence (e.g., Aβ42 (ref. 21 ) and Aβ40-Arctic 18 ) results in kinetic stabilization of the protofibrils formed by the more amyloidogenic sequence. This strategy can be exploited to stabilize protofibrils and facilitate their purification 18 .
stability of the preparation
Considering the situations in which fractionation is not immediately possible, or when protofibrils are not used within a day after fractionation or samples need to be sent to another location, we sought to determine the stability of the protofibrillar preparation over time. To study this, we solubilized synthetic Aβ42 (1 mg ml − 1 , using the DMSO method) and either injected (250 µl) into a Superdex 75 column immediately after solubilization (and centrifugation) or left the solution at 4 °C for a duration of up to 24 h. At 4 and 24 h, the solution was centrifuged and injected (250 µl). We observed that the protofibrillar peak area increased by ~10-15%, as compared with time 0, with a corresponding decline in the monomer peak area (supplementary Fig. 3a) . A TEM analysis of the crude (CR) stock solution after 4 h of incubation at 4 °C revealed predominantly protofibrillar structures and did not show any fibrils (supplementary Fig. 3d,g ). Although the peptide loss due to fibril formation, if any, was minimal, we do not recommend storage of the stock solution for more than 2-4 h.
Similarly, SEC-isolated protofibril fractions (1 ml, ~50 µM) were also incubated at 4 °C for 24 h. Comparison of sample reinjection, soon after fractionation and after 24 h of incubation at 4 °C, showed that the predominant elution was in the void volume (% total peak area: PF = 80-86, M = 14-20) (supplementary Fig. 3b) . TEM analysis, after 24 h of incubation at 4 °C, did not show any mature fibrils; however, protofibrils seemed to cluster with extended incubation (supplementary Fig. 3e,h) .
preparation of a fibrils
The majority of structural and toxicity studies have compared the properties of monomeric and protofibrillar Aβ with that of Aβ fibrils. Aβ fibrils can be generated using purified monomeric preparations or CR Aβ preparations, i.e., those that contain a mixture of monomeric and protofibrillar species, depending on the quantity of fibrils desired and the experimental conditions used. Both methods yield fibrils of similar ThT binding and morphologies.
For highly aggregation-prone sequences (e.g., Aβ42 wt or Aβ40-Arctic), fibrils can be obtained by incubating monomeric Aβ (10-50 µM) at 37 °C under mild agitation for 24-48 h (Figs. 3f and 4h , respectively, for Aβ42 WT or Aβ40-Arctic). Aβ40 fibril formation, from SEC-isolated monomeric Aβ40, requires concentrations ≥50 µM and agitation for 24-48 h 21 . These conditions result in the formation of mature amyloid fibrils with an average diameter of 8-12 nm. The fibrils are characterized by high ThT binding and TEM analysis, and shows an extensive network of intertwining > 1-µm-long filamentous morphologies.
Fibrils can also be prepared from high concentrations of CR Aβ preparations (1-2 mg ml − 1 of Aβ solutions containing monomers, protofibrils and a small amount of fibrils) obtained using one of the methods described for generating protofibrils (the DMSO or NaOH method). Concentrated stock solutions are incubated at 37 °C, under mild agitation, for 24 h. This method generates high ThT-binding fibrils with morphologies similar to those obtained when using purified monomeric Aβ (supplementary Fig. 1d,e) . Preparing fibrils from CR mixtures allows for obtaining fibrils in a short time span and for the generation of large quantities of fibrils for use in high-throughput screening or in vivo studies. Therefore, we recommend the latter method only if experiments demand substantial quantities of fibrils.
sec-isolated a fractions are toxic to cultured neurons
Initial studies showing the neurotoxic nature of protofibrils used Aβ40 protofibrils isolated by SEC using a Sephadex G75 column 14, 20 . Applications of ~20 µM protofibrils produced massive cell loss over a 5 d period, as measured by LDH (Fig. 6a) 14 . This was supported by cytological observations showing loss of neuronal processes and cell bodies (Fig. 6b ) 14 . A concern with cell culture experiments is that the aggregation state of Aβ can change with extended incubation periods ( > 2-6 h), depending on the concentration of the peptide. Cell culture media were collected after 5 d and no fibrils could be observed in either the monomer or protofibril-treated cultures 14 . This suggested that fibrils were not killing the neurons and some Aβ species preceding fibril formation were toxic. Interestingly, similar neuronal death was observed with monomeric fractions after 10-24 h of treatment as the protofibril preparation (Fig. 6a) 
14
, suggesting that monomer fractions can form nonfibrillar Aβ aggregates during the course of the experiment, which might have contributed and/or caused toxicity. Instantaneous readout such as the MTT assay or electrophysiology has confirmed that protofibrils have their own inherent biological activity 14, 20 . In support of the soluble Aβ aggregates causing neurotoxicity, preparations of disaggregated Aβ40-Arctic peptide purified by SEC were found to produce rapid toxicity 65 . Aβ40-Arctic induced neuronal loss, but observations at earlier time points (within 5 h) showed morphological changes in neuronal dendrites and axons, which preceded the rise in LDH (Fig. 6c) 
65
. Similarly, isolating monomeric Aβ42 and applying it to primary neocortical cultures produced a loss of neuronal process (Fig. 6e) that was almost identical to that of Aβ40-Arctic (Fig. 6d) . These findings support the concept that prefibrillar aggregates of Aβ induce synaptic failure, which precedes overt cell loss. These data show the value and versatility of SEC to generate different Aβ preparations in order to probe the pathophysiological relevance of various aggregation states in AD. 
